Screener
Cytokinetics CYTK Balance Sheet Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $255.27M+241% | $129.84M+76.2% | $122.52M+29.2% | $225.47M+381% | $74.94M-60.6% | ||
| $910.42M+16.2% | $688.71M-20.3% | $759.7M-22.6% | $737.07M-23.6% | $783.2M-9.6% | ||
| $24.43M+191% | $6.83M+239% | $17.76M+6.7% | $1.81M+641% | $8.41M— | ||
| $6.53M— | $3.84M— | $0— | —— | $0— | ||
| $1.21B+36.3% | $839.47M-12.2% | $916.98M-17.2% | $977.35M-4.0% | $886.54M-17.0% | ||
| $78.92M+12.4% | $82.44M+22.7% | $79.19M+20.3% | $76M+18.3% | $70.22M+6.9% | ||
| $1.92B+57.0% | $1.27B+0.7% | $1.42B+1.6% | $1.44B0.0% | $1.23B-19.6% | ||
| $20.51M+26.4% | $24.71M+77.2% | $22.34M+9.7% | $22.08M+90.7% | $16.23M+71.4% | ||
| $1.65M+23.0% | $1.65M-96.8% | $1.61M-96.9% | $1.61M— | $1.34M— | ||
| $27.36M+90.0% | $44.81M+246% | $41.18M+257% | $17.28M+50.0% | $14.4M+25.0% | ||
| $181.43M+38.4% | $199.19M+24.7% | $202.45M+12.7% | $142.14M+29.4% | $131.06M+27.5% | ||
| $248.2M+56.0% | $247.21M+169% | $246.38M+164% | $158.75M+70.7% | $159.06M+71.3% | ||
| $2.1B+31.6% | $2.1B+37.2% | $2.08B+35.6% | $1.96B+35.0% | $1.59B+12.7% | ||
| $138K+16.0% | $124K+4.2% | $123K+4.2% | $122K+3.4% | $119K+1.7% | ||
| -$3.89B-29.8% | -$3.69B-29.0% | -$3.49B-29.1% | -$3.3B-29.5% | -$3B-25.4% | ||
| -$173.49M+52.9% | -$826.57M-210% | -$659.63M-387% | -$521.12M-3,646% | -$368.72M-440% | ||
| $1.92B+57.0% | $1.27B+0.7% | $1.42B+1.6% | $1.44B0.0% | $1.23B-19.6% |
FAQ
- What are Cytokinetics's total assets?
- Cytokinetics (CYTK) holds $1.9B in total assets, up 57.0% year over year.
- How much debt does Cytokinetics have?
- Cytokinetics carries $399.0M in total debt against -$173.5M of shareholders' equity, a debt-to-equity ratio of 2.21.
- How much cash does Cytokinetics have?
- Cytokinetics holds $255.3M in cash and equivalents.
- Can Cytokinetics cover its short-term obligations?
- Its current ratio is 6.66 — current assets exceed current liabilities.
- Where does Cytokinetics's balance sheet data come from?
- Every line is extracted from Cytokinetics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
